Table 2 mRNA expression for IL-10, TGF-β and FoxP3 before atorvastatin (visit 1) and after 3 months (visit 2)
HS (n = 17) | Pts (n = 30) | |||||
|---|---|---|---|---|---|---|
P* vs Pts | P** | |||||
Visit 1 | Visit 2 | 1 | 2 | Visit 2 vs 1 | ||
CD4 + CD25+ cells | ||||||
IL-10 | 1.46 (0.202–4.747) | 0.455 | 0.058 | 1.65 (0.3355–4.100) | 1.52 (0.134–3.350) | 0.173 |
TGFβ | 18.070 (11.510–37.770) | 0.111 | 0.178 | 39.850 (14.850–62.850) | 32.300 (15.200–56.000) | 0.185 |
FoxP3 | 252.600 (72.520–389.700) | 0.811 | 0.858 | 138.000 (56.800–581.00) | 274.000 (59.900–534.000) | 0.417 |
CD4 + CD25- cells | ||||||
IL-10 | 0.018 (0.008–0.321) | 0.263 | 0.171 | 0.328 (0.105–0.447) | 0.101 (0.008–0.230) | 0.203 |
TGFβ | 0.851 (0.317–2.055) | 0.097 | 0.428 | 1.780 (0.716–4.575) | 1.640 (0.297–13.700) | 1.000 |
FoxP3 | 0.545 (0.208–0.968) | 0.627 | 0.425 | 0.574 (0.155–3.090) | 0.273 (0.133–0.887) | 0.019 |